Single-Cell Transcriptome Meta-Analysis Reveals Epigenomic and Chromatin Dysregulation in Developing Neurons Derived From Human ESCs With 1q21.1 CNVs.
BPTF chromatin remodeling is the likely molecular choke-point in 1q21.1-linked autism.
01Research in Context
What this study did
Torigata et al. (2026) pooled single-cell gene-readouts from lab-grown neurons. The neurons came from human stem cells carrying 1q21.1 copy-number changes.
They ran a meta-analysis to see which genes stay switched on or off. They paid special attention to autism-linked genes and chromatin-remodeling genes.
What they found
The meta-analysis showed a clear signal: BPTF, a chromatin-remodeling gene, sits at the center of the trouble. Many other autism-risk genes were also switched the wrong way.
The data point to BPTF-guided chromatin changes as a shared pathway in 1q21.1-linked autism.
How this fits with other research
Carter et al. (2016) first argued that stem-cell neurons give us cleaner autism models than animals. Kosuke et al. now supply the numbers that back that claim.
Silleresi et al. (2020) split kids with autism into five language-cognitive profiles. Kosuke’s molecular split adds a second layer: you can now match a child’s profile to possible 1q21.1 and BPTF changes.
Fombonne et al. (2020) mapped high rates of anxiety and ADHD in autistic adults. Kosuke’s BPTF finding gives a possible biological hub that links autism to those comorbidities.
Why it matters
You now have a concrete gene pathway to check when you see 1q21.1 deletions or duplications in a genetic report. BPTF can guide you toward chromatin-targeting drugs or biomarkers that are already on lab benches. Pair this molecular flag with the five language-cognitive profiles from Silleresi et al. (2020) to sharpen your assessment and your treatment plan.
Want CEUs on This Topic?
The ABA Clubhouse has 60+ free CEUs — live every Wednesday. Ethics, supervision & clinical topics.
Join Free →Check the latest genetic report for 1q21.1 status; if present, flag BPTF pathway for team medical follow-up.
02At a glance
03Original abstract
Recent efforts to construct disease-specific multimodal omics databases at single-cell resolution, along with advances in reconstructive technologies such as brain organoids, have opened up opportunities to elucidate the molecular basis of complex human neuropsychiatric diseases. In this study, we performed a meta-analysis to characterize disease-associated regulatory modules by performing single-cell transcriptome analysis of developing neurons from reciprocal human ESC models of CNV in the distal 1q21.1 region. As a result, we observed significant directional enrichment of a series of genes in neuronal cells associated with autism spectrum disorder (ASD), bipolar disorder, and schizophrenia. Correlation analyses revealed that the disease-associated signature primarily targeted epigenetic regulatory mechanisms. We also identified Bromodomain PHD Finger Transcription Factor (BPTF), a key component of the NURF chromatin remodeling complex, as a potential target responsible for transcriptome changes related to human neuropsychiatric diseases, including ASD. We provide a practical and straightforward analytical workflow for utilizing both public data and in-house single-cell omics data from disease models.
Autism research : official journal of the International Society for Autism Research, 2026 · doi:10.1002/aur.70156